A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection.
Husain S, Sage AT, Del Sorbo L, Cypel M, Martinu T, Juvet SC, Mariscal A, Wright J, Chao BT, Shamandy AA, Mousavi SH, Ma J, Wang B, Valero J, Liu M, Landes M, Balachandran S, Hudson K, Ngai M, Capuano M, Gelardi M, Lupia E, Marinowic DR, Friedrich FO, Schmitz CRR, Dos Santos LSM, Barbe-Tuana FM, Jones MH, Kain KC, Mazzulli T, Sabbah S, Keshavjee S.
Husain S, et al. Among authors: barbe tuana fm.
Eur Respir J. 2022 Dec 15;60(6):2200459. doi: 10.1183/13993003.00459-2022. Print 2022 Dec.
Eur Respir J. 2022.
PMID: 36104292
Free PMC article.